To further determine the importance of mTORC1 signaling pathway in NPC proliferation and invasion, S18-BMP2 and 6-10B-BMP2 cells were treated with mTORC1 pharmacological inhibitor (rapamycin). The gene discussed is BMP2; the disease is nasopharyngeal carcinoma.